Literature DB >> 28704174

Evaluation of pulmonary artery pressure in patients with juvenile systemic lupus erythematosus (jSLE).

Amra Adrovic1, Reyhan Dedeoglu, Sezgin Sahin, Kenan Barut, Aida Koka, Dicle Cengiz, Funda Oztunc, Ozgur Kasapcopur.   

Abstract

Juvenile systemic lupus erythematosus (jSLE) is a chronic multisystemic autoimmune disease. Previous studies among adults have shown impaired right ventricular (RV) function in patients with SLE. Also, these patients may develop pulmonary artery hypertension (PAH), which is one of the most threatening complications of SLE. Nevertheless, studies on PAH among jSLE patients are still rare. The aim of this study was to assess the RV function in jSLE patients by Doppler echocardiography (Echo Doppler). We also estimated pulmonary artery systolic pressure (PASP) and mean pulmonary artery pressure (mPAP) in these patients. A total of 38 jSLE patients and 40 sex- and age-matched controls were retrospectively analyzed. All patients underwent combined M-mode, cross-sectional echo, and Doppler Echo examination. The RV function was significantly impaired in jSLE patients compared to controls. PASP and mPAP were normal in 37 out of 38 patients (97.37%), however, the mean values of PASP and mPAP were significantly higher in jSLE patients compared to controls (26.90 mmHg versus 21.71 mmHg and 12.63 mmHg versus 9.89 mmHg, respectively) [p < 0.05]. Only one patient (2.6 %) had elevated mPAP (60 mmHg). The right cardiac catheterization confirmed PAH in this patient. Although PAH was detected only in one patient, there was a marked increase of PAP in our jSLE patients. Overall, PASP and mPAP were significantly higher in jSLE patients compared to healthy controls. Prospective studies with ethnically diverse cohorts could give more insight on the relevance of PAP and PHT in patients with jSLE.

Entities:  

Mesh:

Year:  2018        PMID: 28704174      PMCID: PMC5826676          DOI: 10.17305/bjbms.2017.2178

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  15 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 2.  Childhood-onset systemic lupus erythematosus: an update.

Authors:  Roberto Ezequiel Borgia; Earl D Silverman
Journal:  Curr Opin Rheumatol       Date:  2015-09       Impact factor: 5.006

3.  Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey.

Authors:  Bahar Artim-Esen; Sezgin Şahin; Erhan Çene; Yasemin Şahinkaya; Kenan Barut; Amra Adrovic; Yasemin Özlük; Işın Kılıçaslan; Ahmet Omma; Ahmet Gül; Lale Öcal; Özgür Kasapçopur; Murat İnanç
Journal:  J Rheumatol       Date:  2017-03-15       Impact factor: 4.666

4.  Subclinical right ventricle systolic dysfunction in childhood-onset systemic lupus erythematosus: insights from two-dimensional speckle-tracking echocardiography.

Authors:  G N Leal; K F Silva; C M P França; A C Lianza; J L Andrade; L M A Campos; E Bonfá; C A Silva
Journal:  Lupus       Date:  2014-12-08       Impact factor: 2.911

5.  Pulmonary arterial hypertension in SLE: what do we know?

Authors:  A Prabu; C Gordon
Journal:  Lupus       Date:  2013-10       Impact factor: 2.911

Review 6.  Survival and prognostic factors of systemic lupus erythematosus-associated pulmonary arterial hypertension: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Junyan Qian; Yanhong Wang; Can Huang; Xiaoxi Yang; Jiuliang Zhao; Qian Wang; Zhuang Tian; Mengtao Li; Xiaofeng Zeng
Journal:  Autoimmun Rev       Date:  2015-11-27       Impact factor: 9.754

7.  Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Prevalence and Predictors.

Authors:  Gregorio Miguel Pérez-Peñate; Iñigo Rúa-Figueroa; Gabriel Juliá-Serdá; Fernándo León-Marrero; Antonio García-Quintana; José Ramón Ortega-Trujillo; Celia Erausquin-Arruabarrena; Carlos Rodríguez-Lozano; Pedro Cabrera-Navarro; Nazario Ojeda-Betancor; Miguel Ángel Gómez-Sánchez
Journal:  J Rheumatol       Date:  2015-12-15       Impact factor: 4.666

8.  Asymptomatic pulmonary hypertension in systemic lupus erythematosus.

Authors:  Shereen R Kamel; Gihan M Omar; Ayman F Darwish; Hany T Asklany; Abdou S Ellabban
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2011-09-28

9.  Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.

Authors:  Hong Ki Min; Jae Ho Lee; Seung Min Jung; Jennifer Lee; Kwi Young Kang; Seung-Ki Kwok; Ji Hyeon Ju; Kyung-Su Park; Sung-Hwan Park
Journal:  Korean J Intern Med       Date:  2015-02-27       Impact factor: 2.884

10.  Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients.

Authors:  Can Huang; Mengtao Li; Yongtai Liu; Qian Wang; Xiaoxiao Guo; Jiuliang Zhao; Jinzhi Lai; Zhuang Tian; Yan Zhao; Xiaofeng Zeng
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.